The molecular weight of methotrexate (MTX) makes cutaneous penetration difficult. Oxygen flow could enhance the skin permeation of MTX diluted in the proprietary LP3 carrier system. This pilot study aims to assess the efficacy, safety, and tolerance of oxygen flow–assisted LP3-MTX3% for treating superficial skin cancers.
Übersetzen in:/Translate to:/Traduire vers:
Treating superficial skin cancers